Skip to content

BANKAPOTHEEK: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BANKAPOTHEEK

BE 0840.119.374
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€90,040
2024 · €73,990+€16,050
Equity
€348,128
2024 · €304,532+€43,596
Cash
€168,901
2024 · €157,593+€11,308
Balance sheet total
€538,658
2024 · €485,522+€53,136

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€28,204

    up €28,204 (+18.6%), from €151,326 to €179,530

    of which Other amounts receivable: +€19,216

  • Cash +€11,308

    up €11,308 (+7.2%), from €157,593 to €168,901

    mainly Net result for the year (+€90,040) and Trade debts (+€37,069)

  • Stocks and contracts +€10,546

    up €10,546 (+6.7%), from €156,739 to €167,285

Equity and liabilities
  • Reserves +€38,016

    up €38,016 (+76.3%), from €49,817 to €87,833

  • Trade debts +€37,069

    up €37,069 (+40.0%), from €92,594 to €129,664

  • Other debts -€27,085

    down €27,085 (-100%), from €27,085 to €0

  • Accrued charges and deferred income -€15,276

    down €15,276 (-77.4%), from €19,731 to €4,454

  • Tax, wage and social debts +€14,832

    up €14,832 (+35.7%), from €41,580 to €56,412

    of which Taxes: +€11,304

Income statement
  • Gross operating margin +€28,835

    up €28,835 (+11.6%), from €249,111 to €277,946

  • Taxes +€18,724

    up €18,724 (+102%), from €18,383 to €37,108

  • Financial charges -€10,081

    down €10,081 (-42.8%), from €23,540 to €13,460

  • Staff costs +€4,746

    up €4,746 (+3.8%), from €126,011 to €130,757

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €73,990
Gross operating margin +€28,835
Staff costs -€4,746
Depreciation +€532
Other operating charges +€27
Financial income +€45
Financial charges +€10,081
Taxes -€18,724
Result 2025 €90,040
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€67,269
Investment -€9,517
Financing -€46,444
Cash 2024 €157,593
Net result for the year +€90,040
Depreciation +€6,258
Stocks and contracts -€10,546
Receivables within one year -€28,204
Deferred charges and accrued income +€181
Trade debts +€37,069
Tax, wage and social debts +€14,832
Other debts -€27,085
Accrued charges and deferred income -€15,276
Investment in fixed assets (net) -€9,517
Contributions, distributions and other -€46,444
Cash 2025 €168,901
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €485,522 €538,658 +€53,136 +10.9%
Fixed assets 21/28 €12,581 €15,840 +€3,259 +25.9%
Tangible fixed assets 22/27 €12,218 €15,477 +€3,259 +26.7%
Plant, machinery and equipment 23 €5,601 €12,255 +€6,653 +119%
Furniture and vehicles 24 €6,616 €3,222 -€3,394 -51.3%
Financial fixed assets 28 €363 €363 = 0.0%
Current assets 29/58 €472,941 €522,818 +€49,877 +10.5%
Stocks and contracts in progress 3 €156,739 €167,285 +€10,546 +6.7%
Stocks 30/36 €156,739 €167,285 +€10,546 +6.7%
Amounts receivable within one year 40/41 €151,326 €179,530 +€28,204 +18.6%
Trade receivables 40 €137,893 €146,881 +€8,988 +6.5%
Other amounts receivable 41 €13,433 €32,649 +€19,216 +143%
Cash at bank and in hand 54/58 €157,593 €168,901 +€11,308 +7.2%
Deferred charges and accrued income 490/1 €7,283 €7,102 -€181 -2.5%
Total equity and liabilities 10/49 €485,522 €538,658 +€53,136 +10.9%
Equity 10/15 €304,532 €348,128 +€43,596 +14.3%
Contributions 10/11 €260,293 €260,293 = 0.0%
Reserves 13 €49,817 €87,833 +€38,016 +76.3%
Distributable reserves 133 €49,817 €87,833 +€38,016 +76.3%
Profit (loss) carried forward 14 -€5,578 €2 +€5,580
Amounts payable 17/49 €180,990 €190,530 +€9,540 +5.3%
Amounts payable after more than one year 17 €0 - =
Financial debts 170/4 €0 - =
Amounts payable within one year 42/48 €161,259 €186,075 +€24,816 +15.4%
Trade debts 44 €92,594 €129,664 +€37,069 +40.0%
Suppliers 440/4 €92,594 €129,664 +€37,069 +40.0%
Taxes, remuneration and social security 45 €41,580 €56,412 +€14,832 +35.7%
Taxes 450/3 €15,853 €27,156 +€11,304 +71.3%
Remuneration and social security 454/9 €25,728 €29,256 +€3,528 +13.7%
Other amounts payable 47/48 €27,085 €0 -€27,085 -100%
Accrued charges and deferred income 492/3 €19,731 €4,454 -€15,276 -77.4%
Remuneration, social security and pensions 62 €126,011 €130,757 +€4,746 +3.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,790 €6,258 -€532 -7.8%
Other operating charges 640/8 €1,176 €1,149 -€27 -2.3%
Gross operating margin 9900 €249,111 €277,946 +€28,835 +11.6%
Operating profit (loss) 9901 €115,134 €139,783 +€24,648 +21.4%
Financial income 75/76B €780 €825 +€45 +5.8%
Recurring financial income 75 €780 €825 +€45 +5.8%
Financial charges 65/66B €23,540 €13,460 -€10,081 -42.8%
Recurring financial charges 65 €23,540 €13,460 -€10,081 -42.8%
Profit (loss) for the period before taxes 9903 €92,374 €127,148 +€34,774 +37.6%
Income taxes 67/77 €18,383 €37,108 +€18,724 +102%
Profit (loss) for the period 9904 €73,990 €90,040 +€16,050 +21.7%
Profit (loss) for the period to be appropriated 9905 €73,990 €90,040 +€16,050 +21.7%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.